{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:19:28Z","timestamp":1765545568344},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T00:00:00Z","timestamp":1252540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> Despite advances in conventional treatment, iron\u2010induced cardiomyopathy is still the most frequent cause of death among patients with \u03b2\u2010thalassaemia major. Recent studies have correlated increased myocardial iron content to decreased levels of vitamin D in thalassaemic patients. The aim of this study was to measure parathormone (PTH) and metabolites of vitamin D and consequently to investigate whether these parameters predispose to myocardial iron overload in patients with \u03b2\u2010thalassaemia major.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> In 62 patients (29 M and 33 F, mean age: 22.79\u2003\u00b1\u20036.18\u2003yr) with \u03b2\u2010thalassaemia major levels of intact parathormone (iPTH) and vitamin D metabolites [25(\u039fH)D<jats:sub>3<\/jats:sub> and 1,25(\u039fH)<jats:sub>2<\/jats:sub>D<jats:sub>3<\/jats:sub>] were measured in serum. Additionally, estimation of myocardial iron content was performed by magnetic resonance imaging, whereas mean serum ferritin concentrations were calculated for 1\u2003yr prior to the study.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Results showed markedly decreased levels of serum 25(OH)D<jats:sub>3<\/jats:sub> in 37 patients (60%), whereas 7 patients (11%) had borderline 25(OH)D<jats:sub>3<\/jats:sub> levels (between 50 and 75\u2003nmol\/L). Serum iPTH levels were significantly higher in patients having increased myocardial iron compared to those having normal myocardial iron (44.04\u2003\u00b1\u200322.09\u2003pg\/mL vs. 31.39\u2003\u00b1\u200314.30\u2003pg\/mL, <jats:italic>P<\/jats:italic>\u2003=\u20030.017). Multivariant regression analysis identified PTH levels as the major predictor of increased myocardial iron.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2009.01349.x","type":"journal-article","created":{"date-parts":[[2009,9,10]],"date-time":"2009-09-10T17:31:06Z","timestamp":1252603866000},"page":"64-71","source":"Crossref","is-referenced-by-count":14,"title":["Elevated serum parathormone levels are associated with myocardial iron overload in patients with \u03b2\u2010thalassaemia major"],"prefix":"10.1111","volume":"84","author":[{"given":"Meropi","family":"Dimitriadou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Economou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Tsatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthimia","family":"Vlachaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Fidani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Katzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miranda","family":"Athanassiou\u2010Metaxa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,12,11]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna\u2010Pignatti C","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01218.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(08)70004-3"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(03)00072-5"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10284"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0029-x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm920"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07135.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2822"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.14"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3982"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/10976640009148669"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/10976640600572889"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl336"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-005-0660-1"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.84.11.1302"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124229.40424.80"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.190"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000167193"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.148"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(97)00194-6"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.09.010"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183125"},{"key":"e_1_2_5_25_2","first-page":"67","article-title":"Effects of parathyroidectomy on left ventricular mass in patients with hyperparathyroidism","volume":"21","author":"Sato S","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2007.00211.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007031"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90602-9"},{"key":"e_1_2_5_29_2","first-page":"72","article-title":"Relation between parathyroid hormone and cardiac function in long\u2010term hemodialysis patients","volume":"21","author":"Hara S","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78933-9"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/84.1.18"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/135.11.2739S"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1997.tb08940.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.11.018"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.53.4.347"},{"key":"e_1_2_5_37_2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archinte.1982.00340170191029","article-title":"Combined vitamin D parathyroid defect in thalassemia major","volume":"142","author":"Aloia JF","year":"1982","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.62.5.474"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02549.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/247563a0"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070716"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/366575a0"},{"key":"e_1_2_5_43_2","first-page":"395","article-title":"An experimental histologic study of hypervitaminosis d","volume":"34","author":"Hass GM","year":"1958","journal-title":"Am J Pathol"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.29.4.999"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2009.01349.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2009.01349.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:09:03Z","timestamp":1698728943000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2009.01349.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1600-0609.2009.01349.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2009.01349.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,11]]}}}